In Depth 25 Dec 2024When biotech makes Christmas miracles a reality Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future. December 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 19 Dec 2024After decades of stagnation, is Japan’s biopharma industry set for an upswing? Discover the history of Japan’s biopharma industry and whether it is now set for an upswing after years of stagnation from economic troubles. December 19, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Dec 2024AI + CRISPR: The explosive fusion that will redefine biotechnology With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration. December 18, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding. December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024Is China the future of biotech? Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context. December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2024Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy? Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy. December 11, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024CAR-T cell therapy for lupus: An emerging field with great potential Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder. December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2024The biggest private biotech investments in November 2024 The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024. December 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Dec 2024Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments There is a lot of research going on in the therapeutic field of idiopathic pulmonary fibrosis, in the hope that more treatments reach patients sooner. December 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024The rise of cancer vaccines: A new era in immunotherapy Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors. December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2024Charcot–Marie–Tooth disease: what’s going on in the clinical field? In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease. November 27, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 Nov 2024Can AlphaFold3’s open-source platform revolutionize the way we discover drugs? Find out how Google DeepMind’s AlphaFold3 platform could help scientists revolutionize the field of drug discovery. November 22, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email